Domů

List of major implemented research and development applications of the members of the research team which refer to the issue of the research plan, within the last five years

Papers in impacted journals of the world ISI database

  1. Kolář M., Bardoň J., Vágnerová I. et al.: Occurrence of vancomycin-resistant enterococci in hens in the central region of Moravia. Vet. Med. (Czech). 2000, 45:93-97.
  2. Kolář M., Vágnerová I., Bardoň J., Matoušková I..: Occurrence, origin and spreading of vancomycin-resistant enterococci in hematological patients. Biologia. 2000, 55:305-310.
  3. Bardoň J., Kolář M.: Resistance to antibiotics and production of -lactamase in strains of Plesiomonas shigelloides isolated in animals. Vet. Med. (Czech). 45, 2000:261-265.
  4. Hejnar P., Hamal P., Koukalová D.: Influence of an extended incubation period on values of minimum inhibitory concentrations of antibiotics in Stenotrophomonas maltophilia clinical strains. Microbiologica 2000, 23:415-421.
  5. Kolář M., Bardoň J., Vágnerová I. et al.: Occurrence of vancomycin-resistant enterococci in hens in the central region of Moravia. Vet. Med. (Czech). 2000, 45:93-97.
  6. Faber E., Kujíčková J., Zapletalová J., Knotková R., Dušková L., Heczko M., Hubáček J., Raida L., Papajík T., Kempná J., Kolář M., Hamal P., Indrák K. Infectious complications in patients after autologous peripheral blood stem cell transplantation (APBSCT). Bone Marrow Transplant. 2000, 25( suppl.1):S285.
  7. Hamal P., Schmalreck A.F., Kappe R., Rimek D.: Typing of Candida albicans and Candida glabrata on intensive care units using pulsed field gel electrophoresis (PFGE) and Fourier-transform infrared spectroscopy (FTIR). Mycoses 2000, 43:230.
  8. Petrek M, Drabek J, Kolek V, Zlamal J, Welsh KI, Bunce M, Weigl E, Du Bois R.: CC Chemokine Receptor Gene Polymorphisms in Czech Patients with Pulmonary Sarcoidosis. Resp. Crit. Care Med. 2000, 162:1000-1003.
  9. Hamal P., Kappe R., Rimek D. Rate of transmission and endogenous origin of Candida albicans and Candida glabrata on adult intensive care units studied by pulsed field gel electrophoresis. J. Hosp. Infect., 2001, 49:37-42.
  10. Hamal P., Raclavský V., Hejnar P., Faber E., Pokorný P., Blahut L. Candida parapsilosis as the dominant species causing candidemia in Olomouc hospitals, 1998 – 2000. Mycoses, 2001, 44(suppl.1):28-29.
  11. Hamal P., Raclavský V., Hejnar P. Pulsed-field gel electrophoresis (PFGE) and random amplified polymorphic DNA (RAPD) typing of Candida albicans clinical isolates. Mycoses, 2001, 44(suppl.1):29.
  12. Hejnar P., Kolář M., Hájek V., Koukalová D., Hamal P.: Occurrence of variants with temperature-dependent susceptibility (TDS) to antibiotics among Stenotrophomonas maltophilia clinical strains. Folia Microbiol. 2001, 42:151-155.
  13. Ohkusu M., Raclavský V., Takeo K.: Deficit in oxygen causes G2 budding and unbudded G2 arrest in Cryptococcus neoformans. FEMS Microbiol. Lett. 2001, 204: 29-32.
  14. Kolář M., Urbánek K., Látal T.: Antibiotic selective pressure and development of bacterial resistance. International Journal of Antimicrobial Agents. 2001, 17:357-363.
  15. Hejnar P., Kolář M., Koukalová D.: Values of minimum inhibitory concentrations of antibiotics in Stenotrophomonas maltophilia clinical strains – influence of an extended incubation period. Biologia. 2001, 56:43-47.
  16. Kolář M., Vágnerová I., Urbánek K.: The impact of antibiotic selective pressure on vancomycin-resistance enterococci occurrence. Biologia. 2001, 56:31-35.
  17. Hejnar P., Kolář M., Hájek V., Koukalová D., Hamal P.: Occurrence of variants with temperature-dependent susceptibility (TDS) to antibiotics among Stenotrophomonas maltophilia clinical strains. Folia Microbiol. 2001, 46:151-155.
  18. Hejnar P., Kolář M., Koukalová D.: Values of minimum inhibitory concentrations of antibiotics in Stenotrophomonas maltophilia clinical strains – influence of an extended icubation period. Biologia 2001, 56:43-47.
  19. Hejnar, P., Kolář, M., Hájek, V., Koukalová, D., Hamal, P.: Occurrence of variants with temperature-dependent susceptibility (TDS) to antibiotics among Stenotrophomonas maltophilia clinical strains. Folia Microbiol. 2001, 46:151-155.
  20. Foley P.J., McGrath D.S., Puschiska E., Petřek M., Kolek V. Drábek, J., Lympany P.A., Pantelidis, P., Welsh K,I., Zielinski J., du Bois, R.M.: Human Leukocyty Antigen-DRB1 Position 11 Residues Are a Common Protective Marker for Sarcoidosis. Am. J. Respir. Cell. Mol. Biol. 2001, 25:272 – 277.
  21. Hermans C., Petrek M., Kolek V., Weynand B., Pieters T., Lambert M., Bernard A.: Serum Clara cell protein (CC16), a marker of the integrity of the air-blood barrier in sarcoidosis. Eur. Resp. J. 2001, 18:507–514.
  22. Papajik T., Jedličková K., Kriegová E., Jarošová M., Raida L., Faber E., Hubáček J., Vondráková J., Pikalová Z., Indrák K.: Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up. Neoplasma. 2001; 48(6):501-5.
  23. Patrick J.F., McGrath D.S., Puscinska E., Petřek M., Kolek V., Drábek J., Lympany P.A., Pantelidis P., Welsh K.I, Zielinski J., du Bois R.M.: Human Leukocyte Antigen-DRB1 Position 11 Residues Are a Common Protective Marker for Sarcoidosis. Am. J. Respir. Cell Mol. Biol 2001, 25:272-277.
  24. McGrath D.S., Foley P.J., Petrek M., Izakovicova-Holla L., Kolek V., Veeraraghavan S., Lympany P.A., Pantelidis P., Vasku A., Wells A.U., Welsh K.I., du Bois R.M.: ACE Gene I/D Polymorphism and sarcoidosis Pulmonary Disease Severity. Am. J. Respir. Crit. Care Med. 2001, 164:197-201, 2001.
  25. Trněný M., Černý J., Papajík T., Slvíčková A., Procházka B., Indrák K., Klener P.:Anti cd20 antibody (rituximab) therapy leads to high molecular remission rate with favourable outcome in patients with non-Hodgkin´s lymphoma. Blood, 2001, vol. 98, 11.
  26. Petřek M., Hermans C., Kolek V., Fialová J., Bernard A.: Clara cell protein (CC16) in serum and bronchoalveolar lavage fluid of subjects exposed to asbestos. Biomarkers 2001.
  27. Raclavský V., Ohkusu M., Hrušková P., Takeo K.: Preparation and characterization of Cryptococcus neoformans synchronous culture. J. Microbiol. Methods 2002, 51: 29-33.
  28. Kolář M., Vágnerová I., Látal T., Urbánek K., Typovská H., Hubáček J., Papajík T., Raida L., Fáber E.: The occurrence of vancomycin-resistant enterococci in hematological patients in relation to antibiotic use. Microbiologica, 2002, 25:205-212.
  29. Papajík T., Vlachová Š., Raida L., Jedličková K., Kriegová E., Jarošová M., Faber E., Hubáček J., Vondráková J., Pikalová Z., Indrák K.: Long-term follow-upo minimal residual disease in patients with follicular and diffuse large b-cell lymphoma:the role of polymerase chain reaction detection of cells carrying t(14; 18) in bone marrow and peripheral blood. Annals of Oncology, 2002, 13, 2, 490.
  30. Papajík T., Jarošová M., Raida L., Pikalová Z., Vondráková J., Tichý M., Faber E., Hubáček J., Indrák K.: diagnostic aid of molecular genetic and immuno-flow cytometry in mantle cell lymphoma. Annals of Oncology, 2002, 13, 2, 364.
  31. Ehrmann J. Jr, Kučerová L., Jezdinská V., Papajík T., Galuszková D., Dušek J., Indrák K., Krč I., Ehrmann J.: Fulminant hepatitis caused by Hepatitis B virus infection in patients with hematologic malignancies. Review series, Hepatitis, Issue 2002, 1, 14-15.
  32. Kolář M., Pantůček R., Bardoň J. et al.: Occurrence of antibiotic-resistant bacterial strains isolated in poultry. Vet. Med. (Czech) 2002, 47:52-59.
  33. Hájek V., Pantůček R., Kolář M., Doškar J., Rosypal S.: Comparison of MRSA-Screen latex agglutination, conventional phenotypic methods and mecA gene detection for identification of oxacillin resistance in staphylococci. Biologia, 2002, 57:729-738.
  34. Hejnar P., Chmela Z., Rypka M.: Fatty acid analysis of Stenotrophomonas maltophilia clinical strains showing different susceptibility to antibiotics at 30 and 37 ºC. Folia Microbiol. 2002, 47:742-746.
  35. Drábek, J, Hajdúch, M., Gojová, L, Weigl, E, Mihál, V.: Frequency of 657del5 mutation of NBS1 (nibrin) gene in Czech population by PCR with sequence specific primers. Cancer Genet Cytogenet. 2002, 138, 157-159.
  36. Bruha R., Marecek Z., Spicak J., Hulek P., Lata J., Petrtyl J., Urbanek P., Taimr,P., Volfova M., Dite P.: Double-blind randomized, comparative multicenter study of the effect of terlipressin in the treatment of acute esophageal variceal and/or hypertensive gastropathy bleeding. Hepato-gastroenterology, 2002, 49:1161-1166.
  37. Mrázek F., Sekerová V., Drábek J., Kolek V., du Bois R, Petřek M.: Expression of the chemokine PARC mRNA in bronchoalveolar cells of patients with sarcoidosis. Immunol. Letters 2002, 84:17-22.
  38. Petřek M., Hermans C., Kolek V., Fialová J., Bernard A.: Clara cell protein (CC16) in serum and bronchoalveolar lavage fluid of subjects exposed to asbestos. Biomarkers 2002, 7:58-67.
  39. Petřek M., Gibejova A., Drábek J., Mrazek F., Kolek V., Weigl E., Roland M. du Bois RM.: CC chemokine receptor 5 (CCR) mRNA expression in pulmonary sarcoidosis. Immunol. Letters 2002, 80:189-193.
  40. Petřek M., Hermans C., Kolek V., Fialová J., Bernard A.: Clara cell protein (CC16) in serum and bronchoalveolar lavage fluid of subjects exposed to asbestos. Biomarkers 2002, 7:58-67.
  41. Hutyrová B., Pantelidis P., Drábek J., Žurková M., Kolek V., Lenhart K., Welsh K.I., du Bois R.M., Petřek M.: Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med 2002, 165:148-151.
  42. Petřek M., Kolek V., Szotkowska J., du Bois R.M.: CC and C chemokines expression in pulmonary sarcoidosis. Eur. Respir. J. 2002, 20:1206-1212.
  43. Sekerova V., Subrtova D., Mrazek F., Gibejova A., Kolek V., du Bois R.M., Petrek M.: In vitro pharmacoregulation of CC chemokine ligand (CCL) 5 and its receptor CCR5 in diffuse lung diseases. Mediators Inflamm. 2003;12:215-20.
  44. Lata J., Fejfar T., Krechler T., Musil T., Husova L., Šenkyrik M., Dolina J., Vanasek T.: Spontaneous bacterial peritonitis in the Czech Republic: prevalence and aetiology. European Journal of Gastroenterology and Hepatology, 2003, 15: 739 – 743.
  45. Lata J., Hulek P., Vanasek T.: Management of acute variceal bleeding. Dig Dis, 2003, 21:6-15.
    46. Psotová J., Kolář M., Soušek J., Švagera Z., Vičar J., Ulrichová J.: Biological Activities of Prunella vulgaris Extract. Phytother. Res. 2003, 17:1082-1087.
  46. Čermák P., Kolář M., Látal T. et al.: Frequency and antimicrobial resistance of gram-positive bacterial pathogens from bloodstream infections in the Czech Republic. European Journal of Clinical Microbiology  Infectious Diseases. 2004, 23:794-795.
  47. Ohkusu M., Raclavský V., Takeo K.: Induced synchrony in Cryptococcus neoformans after release from G2-arrest. Antonie van Leeuwenhoek 2004, 85: 37-44.
  48. Hamal P., Dostál J., Raclavský V., Krylová M., Pichová I., Hrušková-Heidingsfeldová O. (2004): Secreted aspartate proteinases, a virulence factor of Candida spp.: Occurrence among clinical isolates. Folia Microbiol. 2004, 49: 491-496.
  49. Svoboda P., Barton R. P., Barbarash O.L., Butylin A.A., Jacobs B.R., Lata J., Haire W.D., Jaff M.R., Firszt C.M., Mouginis T.L., Schuerr D.M., Schulz G.A., Schwartz L.B., El-Shahawy M.A.: Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: A multiple-center, international trial. Critical Care Medicine, 2004, 32:1990-1996.
  50. Raška M., Zemanová E., Kafková L., Běláková J., Vudattu N.K., Kopeček P., Weigl E. Isolation and characterisation of an immunogenic fragment of heat shock protein 60 from Trichophyton mentagrophytes. Mycoses, 2004, 47: str.482-490
  51. Indrák K.: Acute leukemia – clinical register (ALERT) in the Czech Republic 1996-2004. The Hematology Journal, 2004, vol. 5, 2, 094.
  52. Raška M., Rybníkář A., Chumela J., Běláková J., Weigl E. Recombinant protein and DNA vaccines derived from hsp60 protein Trichophyton mentagrophytes control the clinical course of trichophytosis in bovine species and guinea pigs. Mycoses, 2004, 47, str.407-417
  53. Urbánek K., Kolář M., Čekanová L.: Utilisation of macrolides and the development of Streptococcus pyogenes resistance to erythromycin. Pharmacy World and Science. 2005, 27:104-107.
  54. Kolář M., Bardoň J., Sauer P. et al.: Fluoroquinolone-resistant Escherichia coli and Proteus mirabilis in poultry of middle Moravia, Czech Republic. Acta Veterinaria Brno. 2005, 74:249-253.
  55. Raška M., Běláková J., Vudattu N. K., Kafková L., Růžičková K., Kolář Z., Weigl E. Comparison of protective effect of protein and DNA vaccines hsp90 in murine model of systemic candidiasis. Folia Microbiologica, 2005., 50 (1), str.77–82
  56. Urbánek K., Kolář M., Strojil J. et al.: Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients. Pharmacoepidemiology and Drug Safety. 2005, 14:741-745.
  57. Kolář M., Pantůček R., Bardoň J. et al.: Occurrence of vancomycin-resistant enterococci in humans and animals in the Czech Republic between 2002 and 2004. Journal of Medical Microbiology. 2005, 54:965-967.
  58. Andrajati R., Vlček J., Kolář M., Pípalová R.: Survey of surgical antimicrobial prophylaxis in Czech Republic. Pharmacy World  Science. 2005, 27:436-441.
  59. Plachý R., Hamal P., Raclavský V. McRAPD as a new approach to rapid and accurate identification of pathogenic yeasts. J. Microbiol. Meth., 2005, vol. 60, no. 1, p. 107-113.
  60. Šenkyřík M., Dítě P., Dastych M., Příbramská V., Kroupa R.: Variceal bleeding in portal hypertension: bacterial infection and comparison of efficacy of intravenous and per-oral application of antibiotics - a randomized trial. European Journal of Gastroenterology & Hepatology, 2005, 17:1105-1110.
  61. Kolar M., Urbanek K., Vagnerova I., Koukalova D.: The influence of antibiotic use on the occurrence of vancomycin-resistant enterococci. Journal of Clinical Pharmacy and Therapeutics. 2006, 31:67-72.
  62. Raclavský V., Trtková J., Rusková L., Buchta V., Bolehovská R., Vacková M., Hamal P. (2006): The primer R108 performs best in RAPD strain typing of three Aspergillus species frequently isolated from patients. Folia Microbiologica 51, 2006, (no. 1-2, accepted for publication).